Kiniksa Pharmaceuticals International, plc (KNSA) › RevenueKiniksa Pharmaceuticals International, plc (KNSA) — RevenueAnnual figures by period end, from SEC filings.2021-12-31: $38.54M2022-12-31: $220.18M2023-12-31: $270.26M2024-12-31: $423.24M2025-12-31: $677.56M$677.56M2021-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$677.56M+60.1%2026-02-24From 2025-01-012024-12-31$423.24M+56.6%2026-02-24From 2024-01-012023-12-31$270.26M+22.7%2026-02-24From 2023-01-012022-12-31$220.18M+471.2%2025-02-25From 2022-01-012021-12-31$38.54M—2024-02-28From 2021-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)